Integrated Diagnostic Imaging with Biograph mCT
Siemens Healthcare introduces molecular CT, a new concept in integrated imaging that provides a premium imaging platform, and is a practical solution for today's shrinking healthcare budget.
Molecular
Molecular imaging platform planned in Alsace
Alsace BioValley Competitivity Pole is partnering GE Healthcare in a feasibility study of the creation of a technology platform in various fields of molecular imaging to focus on research and translational medicine.
The joint AACC/AACB conference
The American Association for Clinical Chemistry (AACC) and the Australasian Association of Clinical Biochemists (AACB) are joining together for the second time for a conference on major changes facing laboratorians in coming years, under the banner Laboratory Medicine - Into the Future.
Breast cancer: new method is more effective than mammography in women with dense breasts
“Molecular breast imaging” (MBI), a new scintigraphy method developed by US researchers, might improve early detection of breast cancer in women with dense breasts. The results of an initial clinical study were recently presented at the Breast Cancer Symposium of the American Society of Clinical Oncology (ASCO) in Washington, DC, USA.
Molecular imaging software tailors therapy planning and response monitoring
Atlanta-based Velocity Medical Solutions launched VelocityAI, its new molecular imaging software, at the 2008 American Association of Physicists Medicine (AAPM) in July.
New Molecular Imaging Techniques Aim at Detection of Earliest Steps of Disease Development
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level. Molecular imaging allows for unique insights into specific disease mechanisms and holds great promise to change the practice of cardiovascular medicine by facilitating early disease detection,…
New molecular diagnostic research institute
Siemens Healthcare is working on diagnostic tests for early detection and characterziation of a patient's tumor cells. The Cologne laboratories for molecular diagnostics especially concentrate on the research of breast cancer, a disease that still is number one cause of death among women. The results should help to adapt a customized therapy to the individual patient.
Raman spectroscopy improves molecular imaging
A team of Stanford University School of Medicine researchers has developed a new type of imaging system that can illuminate tumors in living subjects-getting pictures with a precision of nearly one-trillionth of a meter.
A novel PET tracer for early detection of Alzheimers
Amyloidb (Ab) plaque formation is a hallmark of Alzheimers disease (AD) and precedes the onset of dementia. Australian researchers reported the first data on the validity in humans of a new PET tracer binding to Ab. Their data suggest that 18F-BAY94-9172 of Bayer Schering Pharma AG can reliably detect Ab deposition and thereby aid early diagnosis, differential diagnosis, and therapeutic…
Cardiovascular molecular imaging - is it ready for internal medicine diagnostics?
Imaging in Internal Medicine is among the main topics for 114th Congress of the German Society of Internal Medicine (March. Wiesbaden). Specialists in internal medicine, radiologists, and nuclear medicine have developed a programme that will not only provide an overview of the values of modern imaging procedures but also tackle controversial subjects.
MR probes for molecular imaging
Molecular imaging aims at the in vivo quantitative visualisation of molecules and molecular events that occur at cellular level. The potential towards clinical translation is huge, because the same modalities used in medical imaging are used in molecular imaging investigations.
Roles in radiology, research, plus a private life?
Apart from spending a year at Johns Hopkins University Hospital, Baltimore, USA, the professor has never worked anywhere other than at the Radiology Department at the University Hospital of Cattinara Hospital, Trieste, of which she is Chairman. Daniela Zimmermann asked her about what women can achieve in this field, as well as the professor's own multifarious roles and research activities.
Innovations to improve cost and quality of patient care
“We have a broad set of products and services that enable healthcare providers to improve the quality and cost of patient care,” said Carestream Health's Chief Executive Officer Kevin J. Hobert with reference to Carestream´s RSNA highlights. “We have digital technology and consulting services that few companies can match, and our integrated imaging and IT solutions are helping healthcare…
Seeking biomarkers
The term 'molecular medicine' has quickly become synonymous with brilliantly revealing images produced by innovative imaging techniques, new biomarkers and contrast agents. At Merck Research Laboratories (MRL) a team of researchers led by Dr Andrew Plump, the firm's Executive Director and Cardiovascular Disease Franchise Integrator, are seeking biomarkers for CVDs, and co-operating with Philips…
Near-infrared contrast agent reveals microcalcifications related to breast and bone cancer
Near-infrared fluorescence mammography works with rays of near-infrared (NIR) light instead of X-rays. Although this is thought to be a very promising technique, there have been no effective contrast agents.
Molecular imaging
In recent years molecular imaging has developed into a hot topic field in medical research, which raised high expectations.
RSNA 2007
About 27,000 healthcare professionals from over 100 countries attended RSNA 2006. These included over 5,000 European clinicians. In addition, over 28,000 people from non-US countries manned about 750 exhibition stands.
Optical molecular imaging
Carestream's molecular imaging group focuses on life sciences, developing high-performance digital imaging systems, imaging agents, film and accessories for the research and drug discovery/development markets.
Euro 900 million for molecular imaging R&D
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
First human ultrahigh-field MRI installed in the Netherlands
The Virtual Institute for Seven Tesla Applications (VISTA) is a partnership of several Dutch universities. To evaluate the benefit of ultrahigh-field MRI the first human 7.0T whole-body research scanner, supplied by Philips Medical Systems, was installed at the Leiden University Medical Center (LUMC). Roland Plasterk, the Durch minister of education, culture and science, attended at the opening…
European Institute of Molecular Imaging founded in Münster, Germany
Besides sophisticated imaging technologies, biomarkers are the key to molecular medicine. Therefore, the development of new and more specific biomarkers is the primary aim of researchers around the world and - since this June - it is also the aim of the new founded European Institute of Molecular Imaging, a cooperation project of the University Münster, Germany and Siemens Medical Solutions.…
Evaluating breast tomosynthesis for the Netherlands
Combining a scientific research laboratory with specialised clinic, the Netherlands Cancer Institute, in the Antoni van Leeuwenhoek Hospital (NKI-AVL), in Amsterdam, aims for a unique interaction of scientific research and clinical application.
Molecular imaging and biomarkers
Whilst Siemens AG in Germany is going through turbulent times, the medical branch of the business remains on steady ground.
It will identify millions with 'silent heart disease'
'If you want to find a needle in a haystack, X-ray is a good tool. Now imagine how much easer that would be if the needle could glow.'
Oncology
In recent years new imaging procedures have delivered many answers and solutions for oncological diagnostics and therapy. However, one question could not be answered: Is a tumour developing?